Last reviewed · How we verify
DWJ1451
At a glance
| Generic name | DWJ1451 |
|---|---|
| Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetics and Safety of DWJ1451 in Healthy Adults (PHASE1)
- Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |